Form 4: Kenvue Director Michael Sneed Receives Significant Deferred Share Unit Grant

Kenvue Inc. Director Michael E. Sneed was granted 7,659 Deferred Share Units (DSUs) on May 22, 2025, increasing his total beneficial ownership to over 25,000 DSUs.

Summary

• Michael E. Sneed, a Director of Kenvue Inc. (KVUE), reported an acquisition of securities.
• The transaction occurred on May 22, 2025.
• Mr. Sneed acquired 7,659 Deferred Share Units (DSUs) under the Issuer's Amended and Restated Deferred Fee Plan for Directors.
• Each DSU represents the right to receive one share of Kenvue common stock upon the termination of Mr. Sneed's directorship.
• The implied value of the underlying common stock for each DSU at the time of grant was $23.5.
• Following this transaction, Mr. Sneed beneficially owns a total of 25,311.664 Deferred Share Units, which includes DSUs acquired as dividend equivalents.

Sentiment

Score: 7

Explanation: The grant of equity to a director is a positive sign of alignment between management and shareholder interests, though it is a routine compensation event rather than a strategic announcement that would significantly alter the company's fundamental outlook.

Positives

• The grant of Deferred Share Units to a director aligns their long-term interests with those of the shareholders, as the value of the DSUs is tied to the company's stock performance.
• This transaction is part of a structured compensation plan, indicating a stable and predictable approach to director remuneration.

Future Outlook

This Form 4 filing pertains to an insider compensation event and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

The grant of equity-based compensation, such as Deferred Share Units, to non-employee directors is a common practice across publicly traded companies. This mechanism is widely used to align the interests of directors with long-term shareholder value creation, reflecting standard corporate governance practices in the industry.

Comparison to Industry Standards

• Director compensation packages in publicly traded companies frequently include equity components like DSUs or restricted stock units (RSUs) to foster alignment with shareholder interests. This practice is consistent with compensation structures observed in peer companies within the consumer health and pharmaceutical sectors, such as Procter & Gamble (PG), Johnson & Johnson (JNJ), and Colgate-Palmolive (CL), which also utilize equity grants as a significant part of their non-executive director remuneration.

Corporate Governance

Related Party Transactions

• Grant of 7,659 Deferred Share Units to Director Michael E. Sneed as part of his compensation under the company's Amended and Restated Deferred Fee Plan for Directors.

Stakeholder Impact

• Shareholders: The equity grant to a director helps align the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

Keywords

Kenvue, KVUE, Michael Sneed, Director, Deferred Share Units, DSU, SEC Form 4, Insider Transaction, Equity Grant, Corporate Governance